Firmenbeschreibung
Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Free float (75%),Triton GP HoldCo SARL (10%),Novo Holdings A/S (8%),Mubadala Investment Company (7%) |
sharesOutstanding: | 177553456.0000 |
ceo: | Dr Christian Wojczewski |
board: | Paul Hitchin, Dr. Cord Dohrmann, Aurélie Dalbiez |
supervisoryBoard: | Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Camilla Macapili Languille, Dr. Duncan McHale, Wes Wheeler, Roland Sackers |
countryID: | 2 |
freeFloat: | 62.1900 |
faceValueCurrencyID: | 1 |
faceValueCurrency: | EUR |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | Deutschland |
countryName: | Deutschland |
Kontakt
name: | Volker Braun |
phone: | +49-40-56081-775 |
fax: | +49-40-56081-222 |
email: | InvestorRelations@evotec.com |
irWebSite: | https://www.evotec.com/en/investor-relations |
Adresse
street: | Essener Bogen 7 |
city: | D-22419 Hamburg |
phone: | +49-40-56081-0 |
fax: | +49-40-56081-222 |
webSite: | www.evotec.com |
email: | info@evotec.com |
Finanzen (kurz)
year: | 2022 | cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 | liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 | sales: | 751.4500 |
investment: | 8.3400 | incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 | employees: | 4952 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2023 | cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 | liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 | sales: | 781.4260 |
investment: | 9.2630 | incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 | employees: | 5061 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2024 | cash: | 306.3870 |
balanceSheetTotal: | 1912.5020 | liabilities: | 959.9770 |
totalShareholdersEquity: | 952.5250 | sales: | 796.9670 |
investment: | 2.4350 | incomeBeforeTaxes: | -193.9770 |
netIncome: | -196.0780 | employees: | 4827 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
Finanzen (kurz)
year: | 2022 |
cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 |
liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 |
sales: | 751.4500 |
investment: | 8.3400 |
incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 |
employees: | 4952 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2023 |
cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 |
liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 |
sales: | 781.4260 |
investment: | 9.2630 |
incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 |
employees: | 5061 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2024 |
cash: | 306.3870 |
balanceSheetTotal: | 1912.5020 |
liabilities: | 959.9770 |
totalShareholdersEquity: | 952.5250 |
sales: | 796.9670 |
investment: | 2.4350 |
incomeBeforeTaxes: | -193.9770 |
netIncome: | -196.0780 |
employees: | 4827 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 2252.4680 | cash: | 510.9090 |
currentAssets: | 903.1620 | fixedAssets: | 1349.3060 |
liabilities: | 464.5730 | nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 | provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 | employees: | 5061 |
property: | 806.5630 | intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 | inventories: | 30.8900 |
accountsReceivable: | 98.3960 | accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 | longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 | minorityInterests: | 0.0000 |
sales: | 781.4260 | netIncome: | -83.9130 |
operatingResult: | -47.5070 | incomeInterest: | -2.4760 |
investments: | 68.5290 | incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 | grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 | cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 | accountingStandard: | IFRS |
equityRatio: | 49.7192 | debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 | liquidityII: | 131.1538 |
netMargin: | -10.7384 | grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 | ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 | preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 | roe: | -7.4928 |
roa: | -3.7254 | netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 | taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 | epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 | incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 | bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 | earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 | netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 | netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 | units: | 1000000 |
balanceSheetTotal: | 1912.5020 | cash: | 306.3870 |
currentAssets: | 681.9640 | fixedAssets: | 1230.5380 |
liabilities: | 344.5850 | nonCurrentLiabilities: | 615.3920 |
provisions: | 81.8040 | totalShareholdersEquity: | 952.5250 |
employees: | 4827 | property: | 823.9370 |
intangibleAssets: | 26.4410 | longTermInvestments: | 2.1380 |
inventories: | 90.4130 | accountsReceivable: | 116.3190 |
accountsPayable: | 85.7920 | liabilitiesTotal: | 959.9770 |
longTermDebt: | 392.7430 | shortTermDebt: | 50.7950 |
minorityInterests: | 0.0000 | sales: | 796.9670 |
netIncome: | -196.0780 | operatingResult: | -142.5220 |
incomeInterest: | -9.2640 | investments: | 50.8570 |
incomeTaxes: | 2.1020 | costGoodsSold: | 682.0860 |
grossProfit: | 114.8810 | minorityInterestsProfit: | 0.0000 |
cashFlow: | 18.2200 | cashFlowInvesting: | -71.1870 |
cashFlowFinancing: | -161.4210 | accountingStandard: | IFRS |
epsBasic: | -1.1100 | incomeBeforeTaxes: | -193.9770 |
currency: | EUR |
year: | 2025 | priceCashFlowRatio: | 62.3289 |
bookValuePerShare: | 5.3647 | marketCap: | 1135631904.5760 |
earningsYield: | -17.3546 | cashFlowPerShare: | 0.1026 |
netAssetsPerShare: | 5.3647 | priceBookValueRatio: | 1.1922 |
netEarningsPerShare: | -1.1043 | currency: | EUR |
Finanzen (ausführlich)
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 2252.4680 |
cash: | 510.9090 |
currentAssets: | 903.1620 |
fixedAssets: | 1349.3060 |
liabilities: | 464.5730 |
nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 |
provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 |
employees: | 5061 |
property: | 806.5630 |
intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 |
inventories: | 30.8900 |
accountsReceivable: | 98.3960 |
accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 |
longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 |
minorityInterests: | 0.0000 |
sales: | 781.4260 |
netIncome: | -83.9130 |
operatingResult: | -47.5070 |
incomeInterest: | -2.4760 |
investments: | 68.5290 |
incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 |
grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 |
cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 |
accountingStandard: | IFRS |
equityRatio: | 49.7192 |
debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 |
liquidityII: | 131.1538 |
netMargin: | -10.7384 |
grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 |
ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 |
roe: | -7.4928 |
roa: | -3.7254 |
netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 |
taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 |
epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 |
incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 |
bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 |
earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 |
netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 |
netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 |
units: | 1000000 |
balanceSheetTotal: | 1912.5020 |
cash: | 306.3870 |
currentAssets: | 681.9640 |
fixedAssets: | 1230.5380 |
liabilities: | 344.5850 |
nonCurrentLiabilities: | 615.3920 |
provisions: | 81.8040 |
totalShareholdersEquity: | 952.5250 |
employees: | 4827 |
property: | 823.9370 |
intangibleAssets: | 26.4410 |
longTermInvestments: | 2.1380 |
inventories: | 90.4130 |
accountsReceivable: | 116.3190 |
accountsPayable: | 85.7920 |
liabilitiesTotal: | 959.9770 |
longTermDebt: | 392.7430 |
shortTermDebt: | 50.7950 |
minorityInterests: | 0.0000 |
sales: | 796.9670 |
netIncome: | -196.0780 |
operatingResult: | -142.5220 |
incomeInterest: | -9.2640 |
investments: | 50.8570 |
incomeTaxes: | 2.1020 |
costGoodsSold: | 682.0860 |
grossProfit: | 114.8810 |
minorityInterestsProfit: | 0.0000 |
cashFlow: | 18.2200 |
cashFlowInvesting: | -71.1870 |
cashFlowFinancing: | -161.4210 |
accountingStandard: | IFRS |
epsBasic: | -1.1100 |
incomeBeforeTaxes: | -193.9770 |
currency: | EUR |
year: | 2025 |
priceCashFlowRatio: | 62.3289 |
bookValuePerShare: | 5.3647 |
marketCap: | 1135631904.5760 |
earningsYield: | -17.3546 |
cashFlowPerShare: | 0.1026 |
netAssetsPerShare: | 5.3647 |
priceBookValueRatio: | 1.1922 |
netEarningsPerShare: | -1.1043 |
currency: | EUR |